BioSpace News Archive

Expedeon AG secures GBP 5 million in debt financing

Expedeon AG secures GBP 5 million in debt financing

September 7, 2018
·
3 min read
Secarna Pharmaceuticals announces poster presentation on targeting RORgt with an innovative antisense oligonucleotides approach at the European Congress of Immunology

Secarna Pharmaceuticals announced today that results from preclinical studies targeting ROR(gamma)t with an innovative antisense oligonucleotide approach will be presented at the 5th European Congress of Immunology (ECI).

September 7, 2018
·
2 min read
Business

EVOTEC AND CHDI FOUNDATION EXTEND ONGOING COLLABORATION TO FIGHT HUNTINGTON’S DISEASE

Evotec AG today announced that CHDI Foundation, Inc. (“CHDI”) has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec.

September 7, 2018
·
5 min read
Drug Development

Botanix Pharmaceuticals Preliminary Final Report

Successfully completed the BTX 1530 Phase 1b acne patient and advanced into Phase 2 clinical development in June 2108

September 7, 2018
·
1 min read
FDA

Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype

Designation Supported by Phase 2b PATHWAY Data That Demonstrated Tezepelumab Significantly Reduced Asthma Exacerbations Compared to Placebo in Severe Asthma Patients

September 7, 2018
·
12 min read
Lone Star Bio

A New Take on Fighting Multi-Drug Resistant Bacteria

UH Researchers Receive $3.5 M to Find Best Combinations of Antibiotics

September 7, 2018
·
3 min read
New PBS listing for Leukaemia Drug ICLUSIG® (ponatinib)

ICLUSIG to be made available to all refractory/relapsed Ph+ ALL patients from September 1, 2018

September 7, 2018
·
10 min read
Deals

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

Thermo Fisher Scientific Inc. has signed a definitive agreement with BD (Becton, Dickinson and Company)

September 7, 2018
·
2 min read
Business

Medigene AG: Medigene announces change in executive leadership team

Planegg announced today that the Chief Financial Officer (CFO), Dr. Thomas Taapken, will leave the Company for personal reasons and will resign from his CFO position effective August 31, 2018.

September 7, 2018
·
2 min read
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology

Interim data for key oncology drug candidate MTD201 establishes favourable clinical profile compared to reference product Novartis’ Sandostatin® LAR® (“SLAR”)

September 7, 2018
·
8 min read